Kirsten L. Gruis

Insider Reports History

Entity
Individual
Location
Two Carlson Parkway, Suite 260, Minneapolis, MN
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kirsten L. Gruis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Chief Medical Officer Stock Option (right to buy) 67K Jun 1, 2023 Direct
DiaMedica Therapeutics Inc. Chief Medical Officer Voting Common Shares, no par value per share 0 $2.80 Jun 1, 2023 Direct

Insider Reports Filed by Kirsten L. Gruis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 Chief Medical Officer
DMAC DiaMedica Therapeutics Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Medical Officer
DMAC DiaMedica Therapeutics Inc. Jan 3, 2022 0 $0 3 Jan 5, 2022 Chief Medical Officer